Back
iShares iBonds Oct 2033 Term TIPS ETF Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Sell
17
IBIJ
iShares iBonds Oct 2033 Term TIPS ETF
Last Price:
$25.89
Seasonality Move:
1.5%
Sell
40
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$110.04
Seasonality Move:
-14.84%
Sell
17
iShares iBonds Oct 2033 Term TIPS ETF (IBIJ)
is a Sell
Is iShares iBonds Oct 2033 Term TIPS ETF a Buy, Sell or Hold?
-
The current iShares iBonds Oct 2033 Term TIPS ETF [IBIJ] share price is $25.89. The Score for IBIJ is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
-
IBIJ is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
40
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Sell
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $110.00. The Score for RYTM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
RYTM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IBIJ Stock Price Chart
What is iShares iBonds Oct 2033 Term TIPS ETF's stock price today?
-
The iShares iBonds Oct 2033 Term TIPS ETF share price today is $25.89Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IBIJ is experiencing slight selling pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $110.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing selling pressure, which indicates risk of future bearish movement.
IBIJ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 35.27 | Sell |
| Chaikin Money Flow: | -5501 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.02 - 26.32) | Sell |
| Bollinger Bands (100): | (26.07 - 26.41) | Sell |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 30.47 | Buy |
| Relative Strength Index (14 RSI): | 52.51 | Buy |
| Chaikin Money Flow: | -355096 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (103.66 - 112.8) | Buy |
| Bollinger Bands (100): | (97.09 - 109.19) | Buy |
IBIJ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.02 | Sell |
| 20-day SMA: | 26.15 | Sell |
| 50-day SMA: | 26.21 | Sell |
| 200-day SMA: | 25.98 | Sell |
| 8-day EMA: | 25.99 | Sell |
| 20-day EMA: | 26.09 | Sell |
| 50-day EMA: | 26.17 | Sell |
| 200-day EMA: | 26.01 | Sell |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 111.96 | Sell |
| 20-day SMA: | 109.02 | Buy |
| 50-day SMA: | 107.04 | Buy |
| 200-day SMA: | 84.45 | Buy |
| 8-day EMA: | 92.44 | Buy |
| 20-day EMA: | 56.32 | Buy |
| 50-day EMA: | 27.32 | Buy |
| 200-day EMA: | 7.56 | Buy |
iShares iBonds Oct 2033 Term TIPS ETF Earnings Growth & IBIJ Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.98 per share, and an increase next year of $0.47 per share.
iShares iBonds Oct 2033 Term TIPS ETF Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||